Last Updated: May 11, 2026

Suppliers and packagers for ONUREG


✉ Email this page to a colleague

« Back to Dashboard


ONUREG

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Bristol ONUREG azacitidine TABLET;ORAL 214120 NDA Celgene Corporation 59572-730-07 7 TABLET, FILM COATED in 1 BLISTER PACK (59572-730-07) 2020-09-01
Bristol ONUREG azacitidine TABLET;ORAL 214120 NDA Celgene Corporation 59572-730-14 14 TABLET, FILM COATED in 1 BOTTLE (59572-730-14) 2020-09-01
Bristol ONUREG azacitidine TABLET;ORAL 214120 NDA Celgene Corporation 59572-740-07 7 TABLET, FILM COATED in 1 BLISTER PACK (59572-740-07) 2020-09-01
Bristol ONUREG azacitidine TABLET;ORAL 214120 NDA Celgene Corporation 59572-740-14 14 TABLET, FILM COATED in 1 BOTTLE (59572-740-14) 2020-09-01
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for ONUREG

Last updated: April 29, 2026

Who Supplies ONUREG (nintedanib?) and Its Key Commercial Inputs?

Result: No complete, accurate supplier map can be produced from the information available in this request.

What can be stated from the request alone: “ONUREG” is a proprietary drug name used in the market; however, supplier identification requires primary evidence tied to (1) the specific active ingredient and dosage form sold as ONUREG, (2) the listed marketing authorization holder (MAH), (3) the manufacturing and release sites, and (4) the raw-material and packaging supply chain entries. None of those data points are provided here.


What counts as a “supplier” for ONUREG?

For drug supply-chain analysis, “supplier” typically breaks into four verifiable categories:

  • Marketing authorization holder (MAH) and product owner
  • Manufacturers and site-of-record for drug substance (API)
  • Manufacturers and site-of-record for drug product (DP)
  • Packers and labeling/secondary packaging suppliers (when disclosed in regulatory dossiers or labeling)

Without the specific ONUREG product definition (strength, dosage form, geography) and its regulatory trail, the supplier set cannot be completed without introducing errors.


What can be directly answered without extra inputs?

Nothing beyond what is already present in the request. No supplier names, sites, or roles are included, and no regulatory artifacts (label, EMA/US FDA product listing, PL/CTD, DMF references, or dossier appendices) are cited.


Key Takeaways

  • “Suppliers for ONUREG” cannot be produced as a complete and accurate list from the provided prompt alone.
  • A defensible supplier map requires regulatory-linked evidence (MAH, DP/API manufacturers, and packaging sites) tied to the specific ONUREG variant sold.

FAQs

  1. Is ONUREG always the same product across countries?
    No. Brand naming can vary by geography and the exact strength/dosage form can change, which changes the supplier evidence trail.

  2. Does “supplier” mean API manufacturer or finished-dose manufacturer?
    In patent and supply-chain analysis, it can mean both, plus packers and labeling suppliers when disclosed.

  3. Can I infer suppliers from the brand name alone?
    Not reliably. Supplier identification needs site-of-record data from labeling or regulatory listings.

  4. Do suppliers change over time?
    Yes. Manufacturing transfers and batch release site changes occur, so the current supplier set must be tied to a dated regulatory record.

  5. What document types normally list ONUREG suppliers?
    EMA EPAR/Annex documents, US labeling and “manufactured for” statements, and the dossier sections that enumerate manufacturing and testing sites.


References

No sources were provided or can be cited from the request.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.